$MRK: Merck Q3 Adj. EPS $2.49 Beats $2.07 Consensus, Revenue Beats on Strong

$MRK

$MRK – Merck Q3 Adj. EPS $2.49 Beats $2.07 Consensus, Revenue Beats on Strong Keytruda Sales

2026-10-29 10:35:19 UTC · TELEGRAM · All $MRK

?? Positive AI Sentiment (+6.8 / 10)

Q3 Sales reached $18.09B vs. $17.31B expected, driven by Keytruda ($8.60B vs. $8.38B)
Adjusted EPS of $2.49 significantly beat expectations of $2.07
FY adjusted gross margin guidance reiterated at approximately 81%

Observed market reaction after signal

4h +4.41% · Peak +5.91%